Background. The incidence of rheumatic heart disease is great in Brazil. We analyzed the distribution of human leukocyte (HLA) antigens in a Brazilian population sample with rheumatic fever or rheumatic heart disease, with the aim of better understanding the mechanisms involved.
Methods and Results. HLA class I (A, B, and C) and class II (DR and DQ) antigen distribution was studied in 40 patients with diagnosis of rheumatic fever or rheumatic heart disease and compared with a control group of 617 healthy individuals for class I typing, from which 118 were drawn for class II typing. A strong correlation between rheumatic fever and rheumatic heart disease and HLA-DRw53 (72.9% in the disease group versus 39%1 in the control group: p=0.00061, relative risk, 4.2; etiologic fraction, 0.43) was found. We also found an increase in the frequency of HLA-DR7 (57.5% in the disease group versus 26 .3% in control group: p=O0.00715; relative risk, 3.8; etiologic fraction, 0.56). HLA class I and HLA-DQ typing did not point to any association with these diseases.
Conclusions. HLA-DR7 and HLA-DRw53 are markers for susceptibility to rheumatic fever and rheumatic heart disease in Brazil. These results could be explained by genetic differences resulting from racial or geographical diversity. (Circulation 1991; 83:1995 -1998 R heumatic fever (RF) consists of nonsuppurative sequelae of infection by group A ,B-hemolytic streptococci. Determination of a genetic pattern of susceptibility to RF and rheumatic heart disease (RHD) has been sought for more than a century. An increased susceptibility to RF or RHD was assigned by Cheadle in 1889.1 Many studies have been conducted in this area of research, with an aim of defining the pattern of inheritance responsible for the observed susceptibility to RF. Some researchers2 have assumed an autosomic recessive model; others3 have dismissed a mendelian pattern of inheritance. Observation of RF or RHD in identical twins4 suggests that if a mendelian pattern is present, penetrance must be incomplete.
Recent studies have tried to uncover specific markers for RF susceptibility. Correlation with blood observed, with a higher incidence of a nonsecretor pattern in affected subjects as well as a reduction of blood group 0 frequency in rheumatic children. 5 Other studies have analyzed human leukocyte (HLA) class I antigens, but no consistent association of these antigens with RF was found.6-15 Subsequent studies of class II antigens have disclosed an association with different HLA-DR alleles according to the population analyzed. [16] [17] [18] [19] [20] Our HLA phenotyping of the Brazilian population with RF or RHD was motivated by both the great incidence of the disease in Brazil and the fact that our population presents considerable interracial mixing (i.e., most individuals are not exclusively caucasian, black, or of indigenous origin). We believe that in a highly mixed population such as that of Brazil, with more diversified haplotypes, the presence of a specific HLA allele implicated in susceptibility to RF and RHD would be more easily apparent. Furthermore, the discordant data from regions outside of Brazil might be clarified.
Methods Patients
We studied 40 patients with RF or RHD who were selected by a pediatric rheumatologist or cardiologist We typed 40 patients for HLA-DR; of these, 37 were typed for HLA-DRw52/53 and HLA-DQ. These patients were compared with the control groups of 118 and 78 unrelated individuals, respectively, for HLA-DR, HLA-DRw52/53, and HLA-DQ, all stemming from the original group of 617 individuals.
In our sample, 23 of 40 patients (57.5%) typed HLA-DR7 compared with 26.3% in the control group.
Calculated x2 was 11.59 with a probability of 0.00065 and a corrected probability of 0.00715 when 11 HLA-DR antigens were considered. Furthermore, the data indicated an RR value of 3.8 and an etiologic fraction of 0.43. The results are shown in Table 1 .
The analysis of 37 patients for HL-A-DRw52/53 disclosed an increased percentage of HLA-DRw53-positive patients (72.9% compared with 39.0% of the control group; x2, 11.73;p=0.00061; RR, 4.2; etiologic fraction, 0.56). The data are given in Table 2. HLA-DQ typing of 37 patients and 78 unrelated controls did not disclose an association with RF or RHD (see Table 3 ). Anastasiou-Nana et al17 described a higher frequency of HLA-DR4 and a lower frequency of HLA-DRw6 in US caucasian patients with RHD.
Ayoub et al18 disclosed an association of RF with HLA-DR2 in black patients and with HLA-DR4 in caucasian patients. Furthermore, in caucasians, they suggested an association between RF and HLADRw9. This association, however, may not be significant because of the very low-control antigen frequencies observed, which give minimal estimates for this allele.
Rajapakse et al'9 defined HLA-DR4 as a genetic marker of RHD in a Saudi Arabian population. Maharaj et a120 disclosed higher frequencies of HLA-DR1 and DRw6 in black patients with chronic heart disease. Patarroyo et a129 noted the existence of a surface marker on peripheral blood mononuclear cells stimulated with pokeweed mitogen, defined by the alloantiserum 883, which reacted with 75% of the patients with RF. The authors were not able to assign a HLA-D-related specificity to this serum. They suggested, however, that the 883 reagent could be recognizing a second Ia locus or, alternatively, a totally different antigen, because this marker was often present as a third specificity in addition to the conventional non-cross-reactive HLA-DR antigens.
Zabriskie et al30 produced a monoclonal antibody, D8/17, that is capable of defining a surface marker on B cells of the majority of patients with RF or RHD. These data suggest that alloantigens are expressed on B cells of patients with RF. Taneja et al31 recently proposed an association with HLA-DQw2 in a study of Indian patients positive for the D8/17 susceptibility marker. However, correlation of these markers with the HLA-DR system has not been clearly established.
We analyzed HLA class I and II antigen distribution in our study population with RF or RHD to characterize an association between RF or RHD and HLA. Our results did not disclose an association of class I antigens with RF or RHD (data not shown).
On the other hand, a very strong correlation of HLA-DR7 with HLA-DRw53 was demonstrated. The correlation with HLA-DR4, which has been found in other populations, was not apparent in the present study, but HLA-DR7, which is included in the HLA-DRw53 group, was abnormally high and significantly correlated with RF and RHD. HLADRw9 was underrepresented in our patient population and absent in the controls; therefore, association analysis was impossible.
No association with HLA-DQ was found, not even with HLA-DQw2, which is the most common antigen in linkage disequilibrium with HLA-DR7. Most HLA-DQ blank individuals (35.1%) were HLA-DR7/DR blank, HLA-DQw2/DQ blank (nine of 14) , and probably homozygous for HLA-DR7 and HLADQw2. The remaining HLA-DQ blank subjects were HLA-DRw8 (four patients), that is, in linkage disequilibrium with HLA-DQw4 not tested by us.
Our calculated etiologic fractions indicate that the presence of the antigen is responsible for 43% (for HLA-DR7) and 56% (for HLA-DRw53) of the factors involved in the pathogenesis of the disease in a susceptible individual.
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